Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Gland Pharma Limited Share Issue/Capital Change 2021

Oct 7, 2021

59319_rns_2021-10-07_77c0cf11-39f5-4a43-9901-ce836868c518.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [59 x 48] intentionally omitted <==

==> picture [298 x 20] intentionally omitted <==

October 7, 2021

BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers 25[th] floor, Dalal Street Mumbai - 400 001 Scrip Code: 543245

National Stock Exchange of India Limited Listing Department Exchange Plaza, 5th floor Plot no. C-1, Block G, Bandra Kurla Complex Bandra (East), Mumbai - 400 051 Symbol : GLAND (ISIN : INE068V01023)

Dear Sir/Madam,

Sub: Allotment of Equity Shares on exercise of ESOP

This is to inform you that pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; the ESOP Compensation Committee of the Board of Directors of the Company has allotted 64,700 Equity shares of Rs.1/- each of the Company, fully paid up, on October 7, 2021 to employees on exercise of their Stock Options pursuant to Gland Pharma Employee Stock Options Scheme, 2019.

Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 164,301,873/- comprising of 164,301,873 Equity shares of face value Rs.1/- each.

This is for your information and records.

Yours truly,

==> picture [217 x 91] intentionally omitted <==

Company Secretary and Compliance Officer

==> picture [596 x 78] intentionally omitted <==